You are here
- Home
Treatment Guidelines for prostate cancer
This section identifies the major Treatment Guidelines relating to Prostate Cancer.
It provides a brief description of each Guideline together with its source and whenever possible, a link to the relevant web-site.
Please click on the relevant link below for a brief summary:
It provides a brief description of each Guideline together with its source and whenever possible, a link to the relevant web-site.
Please click on the relevant link below for a brief summary:
- NCCN – National Comprehensive Cancer Network – Clinical Practice Guidelines – Prostate Cancer – V2.2009
- NICE – National Institute for Health and Clinical Excellence – Prostate Cancer – Diagnosis and Treatment – NICE Guideline 58 – February 2008
- EAU – Guidelines on Prostate Cancer – 2007
- AUA – Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
- ASCO - Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 Update of an American Society of Clinical Oncology Practice Guideline – 2006
- ESMO - Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer – 2005
- ACN – Clinical Practice Guidelines: Evidence based information and recommendations for the management of localised prostate cancer – 2002
- NCCC – Clinical Practice Guidelines – Prostate Cancer – 2000
- RCR COIN/BAUS – Guidelines on the management of prostate cancer – 1999
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
